Breakthrough Announcement Propels Applied Therapeutics (APLT) Stock To Impressive Gains
Applied Therapeutics, Inc. (NASDAQ: APLT) witnessed a notable surge of 39.93% in its stock price on Thursday, culminating in a closing figure of $3.75. This significant uptick in APLT stock followed the release of encouraging interim results from a clinical trial. Applied Therapeutics (APLT) disclosed positive interim findings from the ongoing Phase 3 INSPIRE trial, […]
Insider Selling Report: Applied Therapeutics Inc. [APLT]’s Chief Medical Officer, Perfetti Riccardo, Sells 16,515 Shares
On Jan. 06, Perfetti Riccardo divested U.S. $383,711 in shares of Applied Therapeutics Inc.. The Chief Medical Officer sold 16,515 shares at a price per share of $23.23. The transaction decreased this specific insider’s holdings to 0 shares worth around $0.0 at present. Truist launched its Applied Therapeutics Inc. [APLT] rating to the equivalent of […]
